Status:
UNKNOWN
Immuno-epidemiological and Socio-behavioral Evaluation of Release of Sterile Male Aedes Albopictus Mosquitoes on Human-vector Contacts
Lead Sponsor:
Institut de Recherche pour le Developpement
Conditions:
Mosquito Bite
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This trial is based on 2 complementary components, named ExpAlbo Biomarker and CAPAlbo Questionnaire 1. ExpAlbo Biomarker (Exposure to the Aedes albopictus mosquito): This component concerns the epid...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- To inhabit on a regular basis in the intervention/control area
- To speak French
Exclusion
Key Trial Info
Start Date :
November 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05313126
Start Date
November 9 2021
End Date
June 1 2023
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
population générale (quartier Duparc (Sainte Marie) et Quartier Bois rouge)
La Réunion, France